IQ4I Research & Consultancy Pvt Ltd

13/09/2023

IQ4I Research & Consultancy published a new report on “Pharmaceutical Contract Manufacturing Global Market Forecast To - 2030"

Global pharmaceutical markets are experiencing rapid growth and are projected to continue evolving in the coming years, particularly in the areas of research and development, manufacturing, and formulation. This growth can be attributed to various factors, including the increasing global population, a rise in chronic diseases such as infectious diseases, oncology, and cardiovascular disorders, as well as a significant increase in healthcare expenditures. Additionally, the pharmaceutical industry is witnessing a surge in collaborations, mergers, and acquisitions, further driving its expansion. To keep up with this growing demand and to address various challenges, many pharmaceutical companies are turning to contract manufacturing organizations (CMOs). These companies rely on CMOs for their manufacturing needs, as they may lack well-equipped facilities, advanced technologies, or high containment capabilities. Even when they possess the necessary facilities, they may outsource production to CMOs to save time and have a backup manufacturing option. This increasing trend of outsourcing manufacturing to CMOs is beneficial for both pharmaceutical companies and the service providers. It allows pharmaceutical companies to focus on their core competencies while leaving the manufacturing responsibilities to specialized CMOs. This trend is favoring contract manufacturing service providers and is expected to increase the share in the pharmaceutical manufacturing market. Contract pharmaceutical manufacturing services are mainly focused on the manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF).

Please visit our website: https://lnkd.in/dBwGCycz to know more.
Write to us: [email protected]
Phone: +91-8147030229

, , , , diseases, # infectious diseases, , disorders, Pharmaceutical Ingredients (API), Dosage Formulations (FDF)

21/06/2023

IQ4I Research & Consultancy published a new report on “Respiratory Care Devices Global Market – Forecast To 2029”

Factors that rise their incidence and prevalence of respiratory diseases like Asthma, COPD, and others. The growing elderly population and the subsequent rise in the occurrence of respiratory disorders also contribute to the market's growth. Whereas rising use of non – invasive respiratory care devices, advancements in respiratory care devices, funding for the development of innovative respiratory care technologies and favorable reimbursement are providing immense opportunities to the market. However, product recalls, adverse effects associated with some of the respiratory care devices, availability of alternative respiratory care devices and stringent regulations are hampering the growth of the market.

Please visit our website: https://lnkd.in/dBwGCycz to know more.
Write to us: [email protected]
Phone: +91-8147030229

, , , , , , devices, , , , concentrators, devices, , , , devices, Clarence devices, Powder Inhalers, Dose Inhalers, Mist Inhalers Handheld, # Pulse Oximeters, Pulse Oximeters, , flow meter, devices, Oximeters, , analyzers

25/04/2023

IQ4I Research & Consultancy published a new report on “Glucose Monitoring Global Market – Forecast To 2029”

Factors driving the Glucose Monitoring market are the global rise in the prevalence of diabetes, increasing demand for a less minimally invasive or non-invasive and point-of-care device; increasing R&D investments are driving the market growth, whereas, the growing diffusion of smart devices and digital platforms increasing compliance and management of diabetes is creating opportunities in the coming years. The high cost of the products, frequent product recalls and inadequate reimbursement is restraining the market growth. The stringent regulations for product approval, privacy concerns and safety issues are threats for the market growth.

Please visit our website: https://lnkd.in/dBwGCycz to know more.
Write to us: [email protected]
Phone: +91-8147030229

, , , , , -invasive, -based glucose monitoring, glucose monitoring, glucose monitoring, 's model, # monitors, , ,

07/03/2023

Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's needs; it can be either an acute or chronic condition. Some of the common causes of heart failure include coronary artery disease, heart attack, high blood pressure, atrial fibrillation, valvular heart disease, and cardiomyopathy. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.

To Know more please visit our website: https://iq4i.com/reports/heart-failure-devices-global-market-forecast-to-2029
Write to us: [email protected]
Phone: +91-8147030229

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

06/02/2023

IQ4I Research & Consultancy has published a new report "Pharmaceutical Excipients Global Market-Forecast to 2029".

Factors such as growth in generics and biosimilar drugs, increasing demand for OSDF (oral solid dosage form) excipients, increasing demand for multifunctional excipients, and emergence of drug-coated medical devices. Factors such as increasing demand for solubility-enhancing excipients, rising demand for sustained or controlled release formulations, increase in the prevalence of chronic diseases and rise in the aging population are providing growth opportunities.

To know more please visit our website: https://iq4i.com/reports/pharmaceutical-excipients-global-market-forecast-to-2029
Write to us: [email protected]
Phone:+91-8147030229

, , , ,
, , , , ,
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
, , , , , , , , , , , ,

02/02/2023

IQ4I Research has published a new report "Active Pharmaceutical Ingredients (API) Global Market-Forecast to 2029".

Factors such as, increasing incidence and prevalence of various chronic diseases, adoption of biologics in disease management, increasing regulatory approvals and increasing R&D expenditure & expansion of manufacturing facilities are driving the growth of the API market. While, growing scope for HPAPI and next generation therapeutics such as cell therapy and gene therapy, increasing patent expiration and trend of outsourcing are providing immense opportunity for growth of the API market.

To Know more please visit our website:https://iq4i.com/reports/active-pharmaceutical-ingredient-global-market-forecast-to-2029
Write to us: [email protected]
Phone: +918147030229

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

04/01/2023

Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities in the Embolotherapy global market.

For more information please visit our website: https://iq4i.com/reports/embolotherapy-global-market-forecast-to-2029
Write to us: [email protected]
Phone: +91-8147030229

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

21/12/2022

Increasing trend of biologics outsourcing and increasing approval and demand for biologics and biosimilars are driving the market growth. While, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders, growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins and technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market.

For more information, please visit our website: https://iq4i.com/reports/cell-line-development-services-global-market-forecast-to-2030
Phone:+918147030229
Email:[email protected]

, , , , , , , , , , , , , , , , , , , , , , , , , , , ,

03/11/2022

IQ4I Research & Consultancy has published a new report on "Biologics Outsourcing global market-Forecast to 2030".

Increasing demand for monoclonal antibodies, recombinant proteins based therapies and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins are driving the biologics outsourcing global market.

For more information please visit our website: https://lnkd.in/gQQ6xZW7
Write to us: [email protected]
Call us: +91-8147030229

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Increasing demand for monoclonal antibodies, recombinant proteins based therapies and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the producti...

03/11/2022

IQ4I Research & Consultancy has published a new report on "Biologics Outsourcing global market-Forecast to 2030".

Increasing demand for monoclonal antibodies, recombinant proteins based therapies and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins are driving the biologics outsourcing global market.

For more information please visit our website: https://iq4i.com/reports/biologics-outsourcing-global-market-forecast-to-2030
Write to us: [email protected]
Call us: +91-8147030229

, , , , , , , , , , , , , , , , , , , , , , , , , ,

23/09/2022

IQ4I Research & Consultancy published a new report on “Cell Analysis Global Market – Forecast To 2029”

The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery processes are driving the cell analysis market.

For more information, please visit our website:https://lnkd.in/gQs48K7q
Write to us: [email protected]
Phone:+91-8147030229
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery proces...

22/09/2022

IQ4I Research & Consultancy published a new report on “Interventional Oncology Global Market – Forecast To 2029”

The increasing incidence of cancer cases, increasing geriatric population, and growing adoption of minimally invasive procedures are some of the factors driving the interventional oncology global market.

To know more visit our website: https://iq4i.com/reports/interventional-oncology-global-market-forecast-to-2029
Write to us: [email protected],
Phone: +91-8147030229

, , , , , , , , , , , , , , , , , -TACE,